A Japanese adult case of guanidinoacetate methyltransferase deficiency

Tomoyuki Akiyama, Hitoshi Osaka, Hiroko Shimbo, Tomoshi Nakajiri, Katsuhiro Kobayashi, Makio Oka, Fumika Endoh, Harumi Yoshinaga

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Citations (Scopus)

Abstract

Guanidinoacetate methyltransferase (GAMT) deficiency is a rare disorder of creatine synthesis resulting in cerebral creatine depletion. We present a 38-year-old patient, the first Japanese case of GAMT deficiency. Developmental delay started after a few months of age with a marked delay in language, which resulted in severe intellectual deficit. She showed hyperactivity and trichotillomania from childhood. Epileptic seizures appeared at 18 months and she had multiple types of seizures including epileptic spasms, brief tonic seizures, atypical absences, complex partial seizures with secondary generalization, and “drop” seizures. They have been refractory to multiple antiepileptic drugs. Although there have been no involuntary movements, magnetic resonance imaging revealed T2 hyperintense lesions in bilateral globus pallidi. Motor regression started around 30 years of age and the patient is now able to walk for only short periods. Very low serum creatinine levels measured by enzymatic method raised a suspicion of GAMT deficiency, which was confirmed by proton magnetic resonance spectroscopy and urinary guanidinoacetate assay. GAMT gene analysis revealed that the patient is a compound heterozygote of c.578A>G, p.Gln193Arg and splice site mutation, c.391G>C, p.Gly131Arg, neither of which have been reported in the literature. We also identified two aberrant splice products from the patient’s cDNA analysis. The patient was recently started on supplementation of high-dose creatine and ornithine, the effects of which are currently under evaluation. Although rare, patients with developmental delay, epilepsy, behavioral problems, and movement disorders should be vigorously screened for GAMT deficiency, as it is a treatable disorder.

Original languageEnglish
Title of host publicationJIMD Reports
PublisherSpringer
Pages65-69
Number of pages5
DOIs
Publication statusPublished - Jan 1 2014

Publication series

NameJIMD Reports
Volume12
ISSN (Print)2192-8304
ISSN (Electronic)2192-8312

Fingerprint

Guanidinoacetate N-Methyltransferase
Creatine
Epilepsy
Seizures
Magnetic resonance spectroscopy
Trichotillomania
Ornithine
Language Development Disorders
Magnetic resonance
Globus Pallidus
Refractory materials
Anticonvulsants
Dyskinesias
Movement Disorders
Spasm
Heterozygote
Assays
Creatinine
Complementary DNA
Genes

Keywords

  • Creatine supplementation
  • Creatine synthesis
  • Intellectual disability
  • Involuntary movement
  • Splice site mutation

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)

Cite this

Akiyama, T., Osaka, H., Shimbo, H., Nakajiri, T., Kobayashi, K., Oka, M., ... Yoshinaga, H. (2014). A Japanese adult case of guanidinoacetate methyltransferase deficiency. In JIMD Reports (pp. 65-69). (JIMD Reports; Vol. 12). Springer. https://doi.org/10.1007/8904_2013_245

A Japanese adult case of guanidinoacetate methyltransferase deficiency. / Akiyama, Tomoyuki; Osaka, Hitoshi; Shimbo, Hiroko; Nakajiri, Tomoshi; Kobayashi, Katsuhiro; Oka, Makio; Endoh, Fumika; Yoshinaga, Harumi.

JIMD Reports. Springer, 2014. p. 65-69 (JIMD Reports; Vol. 12).

Research output: Chapter in Book/Report/Conference proceedingChapter

Akiyama, T, Osaka, H, Shimbo, H, Nakajiri, T, Kobayashi, K, Oka, M, Endoh, F & Yoshinaga, H 2014, A Japanese adult case of guanidinoacetate methyltransferase deficiency. in JIMD Reports. JIMD Reports, vol. 12, Springer, pp. 65-69. https://doi.org/10.1007/8904_2013_245
Akiyama T, Osaka H, Shimbo H, Nakajiri T, Kobayashi K, Oka M et al. A Japanese adult case of guanidinoacetate methyltransferase deficiency. In JIMD Reports. Springer. 2014. p. 65-69. (JIMD Reports). https://doi.org/10.1007/8904_2013_245
Akiyama, Tomoyuki ; Osaka, Hitoshi ; Shimbo, Hiroko ; Nakajiri, Tomoshi ; Kobayashi, Katsuhiro ; Oka, Makio ; Endoh, Fumika ; Yoshinaga, Harumi. / A Japanese adult case of guanidinoacetate methyltransferase deficiency. JIMD Reports. Springer, 2014. pp. 65-69 (JIMD Reports).
@inbook{563dfa9fbff14b10860cd959ae1cc9a8,
title = "A Japanese adult case of guanidinoacetate methyltransferase deficiency",
abstract = "Guanidinoacetate methyltransferase (GAMT) deficiency is a rare disorder of creatine synthesis resulting in cerebral creatine depletion. We present a 38-year-old patient, the first Japanese case of GAMT deficiency. Developmental delay started after a few months of age with a marked delay in language, which resulted in severe intellectual deficit. She showed hyperactivity and trichotillomania from childhood. Epileptic seizures appeared at 18 months and she had multiple types of seizures including epileptic spasms, brief tonic seizures, atypical absences, complex partial seizures with secondary generalization, and “drop” seizures. They have been refractory to multiple antiepileptic drugs. Although there have been no involuntary movements, magnetic resonance imaging revealed T2 hyperintense lesions in bilateral globus pallidi. Motor regression started around 30 years of age and the patient is now able to walk for only short periods. Very low serum creatinine levels measured by enzymatic method raised a suspicion of GAMT deficiency, which was confirmed by proton magnetic resonance spectroscopy and urinary guanidinoacetate assay. GAMT gene analysis revealed that the patient is a compound heterozygote of c.578A>G, p.Gln193Arg and splice site mutation, c.391G>C, p.Gly131Arg, neither of which have been reported in the literature. We also identified two aberrant splice products from the patient’s cDNA analysis. The patient was recently started on supplementation of high-dose creatine and ornithine, the effects of which are currently under evaluation. Although rare, patients with developmental delay, epilepsy, behavioral problems, and movement disorders should be vigorously screened for GAMT deficiency, as it is a treatable disorder.",
keywords = "Creatine supplementation, Creatine synthesis, Intellectual disability, Involuntary movement, Splice site mutation",
author = "Tomoyuki Akiyama and Hitoshi Osaka and Hiroko Shimbo and Tomoshi Nakajiri and Katsuhiro Kobayashi and Makio Oka and Fumika Endoh and Harumi Yoshinaga",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/8904_2013_245",
language = "English",
series = "JIMD Reports",
publisher = "Springer",
pages = "65--69",
booktitle = "JIMD Reports",

}

TY - CHAP

T1 - A Japanese adult case of guanidinoacetate methyltransferase deficiency

AU - Akiyama, Tomoyuki

AU - Osaka, Hitoshi

AU - Shimbo, Hiroko

AU - Nakajiri, Tomoshi

AU - Kobayashi, Katsuhiro

AU - Oka, Makio

AU - Endoh, Fumika

AU - Yoshinaga, Harumi

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Guanidinoacetate methyltransferase (GAMT) deficiency is a rare disorder of creatine synthesis resulting in cerebral creatine depletion. We present a 38-year-old patient, the first Japanese case of GAMT deficiency. Developmental delay started after a few months of age with a marked delay in language, which resulted in severe intellectual deficit. She showed hyperactivity and trichotillomania from childhood. Epileptic seizures appeared at 18 months and she had multiple types of seizures including epileptic spasms, brief tonic seizures, atypical absences, complex partial seizures with secondary generalization, and “drop” seizures. They have been refractory to multiple antiepileptic drugs. Although there have been no involuntary movements, magnetic resonance imaging revealed T2 hyperintense lesions in bilateral globus pallidi. Motor regression started around 30 years of age and the patient is now able to walk for only short periods. Very low serum creatinine levels measured by enzymatic method raised a suspicion of GAMT deficiency, which was confirmed by proton magnetic resonance spectroscopy and urinary guanidinoacetate assay. GAMT gene analysis revealed that the patient is a compound heterozygote of c.578A>G, p.Gln193Arg and splice site mutation, c.391G>C, p.Gly131Arg, neither of which have been reported in the literature. We also identified two aberrant splice products from the patient’s cDNA analysis. The patient was recently started on supplementation of high-dose creatine and ornithine, the effects of which are currently under evaluation. Although rare, patients with developmental delay, epilepsy, behavioral problems, and movement disorders should be vigorously screened for GAMT deficiency, as it is a treatable disorder.

AB - Guanidinoacetate methyltransferase (GAMT) deficiency is a rare disorder of creatine synthesis resulting in cerebral creatine depletion. We present a 38-year-old patient, the first Japanese case of GAMT deficiency. Developmental delay started after a few months of age with a marked delay in language, which resulted in severe intellectual deficit. She showed hyperactivity and trichotillomania from childhood. Epileptic seizures appeared at 18 months and she had multiple types of seizures including epileptic spasms, brief tonic seizures, atypical absences, complex partial seizures with secondary generalization, and “drop” seizures. They have been refractory to multiple antiepileptic drugs. Although there have been no involuntary movements, magnetic resonance imaging revealed T2 hyperintense lesions in bilateral globus pallidi. Motor regression started around 30 years of age and the patient is now able to walk for only short periods. Very low serum creatinine levels measured by enzymatic method raised a suspicion of GAMT deficiency, which was confirmed by proton magnetic resonance spectroscopy and urinary guanidinoacetate assay. GAMT gene analysis revealed that the patient is a compound heterozygote of c.578A>G, p.Gln193Arg and splice site mutation, c.391G>C, p.Gly131Arg, neither of which have been reported in the literature. We also identified two aberrant splice products from the patient’s cDNA analysis. The patient was recently started on supplementation of high-dose creatine and ornithine, the effects of which are currently under evaluation. Although rare, patients with developmental delay, epilepsy, behavioral problems, and movement disorders should be vigorously screened for GAMT deficiency, as it is a treatable disorder.

KW - Creatine supplementation

KW - Creatine synthesis

KW - Intellectual disability

KW - Involuntary movement

KW - Splice site mutation

UR - http://www.scopus.com/inward/record.url?scp=84896137037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896137037&partnerID=8YFLogxK

U2 - 10.1007/8904_2013_245

DO - 10.1007/8904_2013_245

M3 - Chapter

AN - SCOPUS:84896137037

T3 - JIMD Reports

SP - 65

EP - 69

BT - JIMD Reports

PB - Springer

ER -